Study: Blood Cancer Treatment Found to Kill Latent HIV-Infected Cells, Possible New Treatment

Although antiretroviral therapies are the standard of care treatment for those with HIV, the drugs cannot target latent infections; however, venetoclax, a blood cancer treatment, shows promise.

Related Keywords

Denmark ,Australia ,Melbourne ,Victoria ,Youry Kim ,Marc Pellegrini ,Philip Arandjelovic ,Genentech ,Peter Doherty Institute For Infection ,Eliza Hall Institute ,Doherty Institute ,Eliza Hall Institute Of Medical Research ,Peter Doherty Institute ,Medical Research ,Eliza Hall ,Centenary Institute ,Cell Reports ,